Drugs / Whole peanut extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01170286 | Jul 2010 → Feb 2012 | food allergy | DBV Technologies | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Whole peanut extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01170286 ↗ |
| Modality | Protein / enzyme biologic | “peanut proteins” NCT01170286 ↗ |
| Route | Other | “epicutaneous application” NCT01170286 ↗ |